Scott Investment Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$940K Hold
12,000
2.16% 22
2023
Q2
$1.06M Hold
12,000
2.38% 18
2023
Q1
$967K Hold
12,000
2.23% 22
2022
Q4
$933K Buy
12,000
+3,100
+35% +$251K 2.25% 20
2022
Q3
$719K Sell
8,900
-53,000
-86% -$4.76M 1.93% 30
2022
Q2
$5.56M Hold
61,900
3.7% 7
2022
Q1
$6.87M Buy
61,900
+21,800
+54% +$2.3M 4.13% 6
2021
Q4
$4.15M Hold
40,100
2.59% 22
2021
Q3
$5.03M Hold
40,100
3.45% 18
2021
Q2
$4.98M Hold
40,100
3.5% 13
2021
Q1
$4.74M Buy
40,100
+2,000
+5% +$234K 3.48% 14
2020
Q4
$4.46M Buy
+38,100
New +$4.19M 3.53% 14

Other funds holding MDT

Scott Investment Partners's MDT Position: Q3 2023 in Review

Scott Investment Partners held its Medtronic (MDT) position steady in Q3 2023 at 12,000 shares worth $940K. The position accounts for 2.16% of the portfolio, ranked #22.

Scott Investment Partners first reported a position in MDT in Q4 2020 and has held it in 12 quarters since. The position peaked at $6.87M in Q1 2022. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Scott Investment Partners held 12,000 shares of Medtronic worth $940K as of Q3 2023.
  • Scott Investment Partners left its Medtronic share count unchanged in Q3 2023.
  • Medtronic made up 2.16% of Scott Investment Partners's portfolio in Q3 2023, its #22 holding.
  • Scott Investment Partners first reported a position in Medtronic in Q4 2020 and has held it in 12 quarters since.
  • Scott Investment Partners's Medtronic position peaked at $6.87M in Q1 2022.
  • 1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Scott Investment Partners's 13F filing for Q3 2023, filed 1 Nov 2023.